Het Imeldaziekenhuis is een middelgroot regionaal, katholiek ziekenhuis in Bonheiden. Het ziekenhuis is vernoemd naar de zalige Imelda Lambertini.

During the past decade, Imelda GI clinical research center conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Imelda GI clinical research center" #1 sponsor was "Egetis Therapeutics" with 2 trials, followed by "Imelda GI Clinical Research Center" with 2 trials sponsored, "Arena Pharmaceuticals" with 1 trials sponsored, "Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Imelda GI clinical research center" #1 collaborator was "Solasia Pharma K.K." with 2 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Centocor BV" with 1 trials as a collaborator, "Imelda GI Clinical Research Center" with 1 trials as a collaborator and "Sapporo Medical University" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Imelda GI clinical research center" are "Ulcerative Colitis" (5 trials), "Chemotherapy-induced Peripheral Neuropathy" (2 trials), "Colorectal Cancer" (2 trials), "Crohn Disease" (1 trials) and "Crohn's Disease" (1 trials). Many other conditions were trialed in "Imelda GI clinical research center" in a lesser frequency.

Most popular intervention types in "Imelda GI clinical research center" are "Drug" (5 trials), "Diagnostic Test" (2 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Calmangafodipir (5 µmol/kg)" (2 trials), "Etrasimod" (2 trials), "Calmangafodipir (2 µmol/kg)" (1 trials) and "Red Density" (1 trials). Other intervention names were less common.

The vast majority of trials in "Imelda GI clinical research center" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Imelda GI clinical research center". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Imelda GI clinical research center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Imelda GI clinical research center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".